CVE detail

CVE-2020-7285 — CVE-2020-7285

Published 2020-05-08 · Modified 2026-06-17 · Vendor mcafee · Product mvision_endpoint · Source nvd

HIGH

severity

CVSS-derived band

7.8

CVSS v3

0–10 scale

0.0025

EPSS probability

exploitation probability, 30d

17.0%

EPSS percentile

percentile vs all CVEs

NOT LISTED

CISA KEV

known exploited catalog

Description

Privilege Escalation vulnerability in McAfee MVISION Endpoint prior to 20.5.0.94 allows a malicious script or program to perform functions that the local executing user has not been granted access to.

Remediation

No vendor-published fix data in our corpus for this CVE. Check the references below or the vendor's PSIRT / security advisories page.

References

cvedb.io · NVD · CISA KEV · FIRST EPSS · vendor advisories (CVE Program List v5). Informational only, no warranty — verify every remediation against the vendor advisory before acting on it. This product uses data from the NVD API but is not endorsed or certified by the NVD, CISA, FIRST.org or any vendor named. CVE® is a registered trademark of The MITRE Corporation.